Zhang, Le
Wang, Weixue
Ge, Shaohua
Li, Hongli
Bai, Ming
Duan, Jingjing
Yang, Yuchong
Ning, Tao
Liu, Rui
Wang, Xia
Ji, Zhi
Wang, Feixue
Zhang, Haiyang
Ba, Yi
Deng, Ting
Funding for this research was provided by:
Beijing Xisike Clinical Oncology Research Foundation (Y-HR2019-0347)
Article History
Received: 10 September 2022
Accepted: 20 February 2023
First Online: 5 March 2023
Declarations
:
: The study was approved by the independent ethics committees of Tianjin Medical University Cancer Institute and Hospital (E2020682) and was performed in accordance with the Declaration of Helsinki. All enrolled patients were provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.